Xeomin 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFL7Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,027
Award facts
- Contract value 100% obligated
- $48,027.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 29, 2026, provides Xeomin 200 Unit Vials to the Defense Logistics Agency (DLA) through AmerisourceBergen Drug Corp at a fixed price of $48,027.20, with completion expected by February 20, 2026. The award is non-competitive and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031. This IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling efficient procurement of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a critical vendor within the federal pharmaceutical supply chain and has demonstrated substantial capability in fulfilling large-scale medical procurement requirements for military and veteran healthcare systems. Xeomin, a botulinum toxin product used in medical and therapeutic applications, will be supplied from the company's Pennsylvania location. The firm fixed-price structure and non-set-aside designation reflect standard competitive procurement practices under the broader IDC framework, positioning this delivery order as part of the routine pharmaceutical resupply operations supporting the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FFL7Z?
SPE2DR26FFL7Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL7Z worth?
The government has obligated $48,027 on SPE2DR26FFL7Z.
Is contract SPE2DR26FFL7Z an order under another contract?
Yes. SPE2DR26FFL7Z is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL7Z competed?
The extent of competition for SPE2DR26FFL7Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award